Parcare Community Health Network INC
Parcare Community Health Network INC was paid $88.45M by Medicaid between May 2018 and Dec 2024, across 264 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoPARCARE COMMUNITY HEALTH NETWORK INC
BROOKLYN, NY 11205
BROOKLYN, NY 11205
33aNPI1730454083assigned 03/20/2012
33bProvider typeSpecialist
28Total paid$88.45M
24GClaims1,118,511
24DCodes billed264
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#1 of 1,221
Median peer was paid$45K
This provider vs. median1,956×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,416 | $295K | |
| 2019 | 27,090 | $2.04M | |
| 2020 | 184,397 | $13.89M | |
| 2021 | 269,179 | $18.67M | |
| 2022 | 206,977 | $16.51M | |
| 2023 | 217,025 | $18.71M | |
| 2024incomplete | 210,427 | $18.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 169,080 | 136,544 | $22.61M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.1% | 50,078 | 48,979 | $7.20M |
| 10040 | 7.0% | 24,114 | 17,547 | $6.17M | |
| 99441 | 5.9% | 37,167 | 33,710 | $5.22M | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.6% | 28,352 | 24,543 | $4.10M |
| 99308 | Subsequent nursing facility care, per day, straightforward | 4.6% | 66,785 | 26,197 | $4.03M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.4% | 57,790 | 41,213 | $3.88M |
| 99442 | 2.9% | 23,079 | 20,773 | $2.61M | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.4% | 14,599 | 14,375 | $2.10M |
| 17110 | 2.2% | 6,161 | 4,744 | $1.97M | |
| 17360 | 2.0% | 8,857 | 5,973 | $1.77M | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 26,644 | 21,088 | $1.73M |
252 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.8% | 10,746 | $1.63M |
| 99051 | 1.8% | 133,328 | $1.62M | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 44,162 | $1.59M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.5% | 19,774 | $1.34M |
| 99201 | 1.3% | 8,160 | $1.15M | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.3% | 1,908 | $1.14M |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 1.3% | 13,420 | $1.13M |
| 15783 | 1.1% | 3,780 | $976K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 22,824 | $976K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 5,944 | $889K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 20,625 | $816K |
| 17340 | <1% | 4,039 | $615K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 20,218 | $589K |
| 99000 | <1% | 22,394 | $539K | |
| 0101T | <1% | 1,227 | $536K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 274 | $500K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 20,186 | $457K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14,323 | $454K |
| 20550 | <1% | 1,514 | $446K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,316 | $431K |
| 99443 | <1% | 1,813 | $396K | |
| 15788 | <1% | 4,641 | $372K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,832 | $314K |
| 12001 | <1% | 616 | $269K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 13,642 | $260K |
| 97162 | <1% | 1,609 | $251K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,462 | $243K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12,332 | $230K |
| 76801 | <1% | 1,936 | $226K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 3,031 | $217K |
| 15780 | <1% | 748 | $211K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,888 | $178K |
| 76820 | <1% | 3,031 | $175K | |
| 99305 | <1% | 1,595 | $173K | |
| G0295 | Electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses | <1% | 1,267 | $170K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,041 | $165K |
| 11721 | <1% | 1,880 | $151K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,545 | $146K |
| 99401 | <1% | 3,060 | $143K | |
| 97164 | <1% | 1,161 | $137K | |
| 98960 | <1% | 5,070 | $125K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,055 | $121K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 797 | $116K |
| 36415 | Collection of venous blood by venipuncture | <1% | 23,341 | $116K |
| 92526 | <1% | 779 | $107K | |
| 11730 | <1% | 1,092 | $98K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 175 | $97K |
| 92587 | <1% | 1,559 | $91K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 673 | $84K |
| 76942 | <1% | 425 | $79K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 489 | $74K |
| 76818 | <1% | 598 | $69K | |
| 97803 | <1% | 1,172 | $67K | |
| 99385 | <1% | 462 | $62K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 398 | $61K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 287 | $59K |
| 99050 | <1% | 6,413 | $57K | |
| 97116 | <1% | 1,535 | $53K | |
| 15786 | <1% | 743 | $53K | |
| 11755 | <1% | 88 | $51K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 441 | $49K |
| 99307 | <1% | 778 | $47K | |
| 99349 | <1% | 735 | $47K | |
| 97161 | <1% | 352 | $45K | |
| 92522 | <1% | 260 | $42K | |
| 10060 | <1% | 131 | $41K | |
| 99386 | <1% | 302 | $41K | |
| 97010 | <1% | 3,726 | $38K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 245 | $37K |
| 10120 | <1% | 107 | $35K | |
| 99205 | Prolong outpt/office vis | <1% | 237 | $34K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 773 | $31K |
| 92567 | <1% | 417 | $30K | |
| 17111 | <1% | 86 | $28K | |
| 11200 | <1% | 159 | $28K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 189 | $25K |
| 99402 | <1% | 306 | $25K | |
| V2020 | Frames, purchases | <1% | 340 | $24K |
| 20552 | <1% | 181 | $23K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 85 | $22K |
| G0008 | Administration of influenza virus vaccine | <1% | 1,675 | $20K |
| 87631 | <1% | 387 | $20K | |
| 0223U | <1% | 54 | $20K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,134 | $20K |
| 97168 | <1% | 183 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,530 | $19K |
| 20553 | <1% | 145 | $19K | |
| 69210 | <1% | 292 | $17K | |
| 90674 | <1% | 702 | $16K | |
| 92523 | <1% | 86 | $16K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 56 | $16K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 27 | $15K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 338 | $15K |
| 92250 | <1% | 146 | $14K | |
| 97602 | <1% | 22 | $12K | |
| 76813 | <1% | 103 | $12K | |
| 90715 | <1% | 470 | $11K | |
| 11900 | <1% | 54 | $10K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 115 | $9K |
| 81025 | <1% | 2,727 | $8K | |
| 92060 | <1% | 86 | $7K | |
| 97166 | <1% | 45 | $7K | |
| 58300 | <1% | 41 | $7K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 38 | $6K |
| 36416 | <1% | 288 | $6K | |
| 99454 | <1% | 208 | $6K | |
| 92310 | <1% | 22 | $5K | |
| 97533 | <1% | 278 | $5K | |
| 97014 | <1% | 452 | $5K | |
| 99404 | <1% | 37 | $5K | |
| 90686 | <1% | 288 | $5K | |
| 97129 | <1% | 198 | $5K | |
| 97165 | <1% | 38 | $4K | |
| 99457 | <1% | 173 | $4K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 300 | $4K |
| 90697 | <1% | 218 | $4K | |
| 76881 | <1% | 201 | $4K | |
| 99350 | Prolong home eval add 15m | <1% | 73 | $4K |
| 86769 | <1% | 229 | $3K | |
| 99177 | <1% | 1,017 | $3K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 66 | $3K |
| 29540 | <1% | 15 | $3K | |
| 97163 | <1% | 19 | $3K | |
| 97802 | <1% | 65 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12,469 | $3K |
| 90746 | <1% | 117 | $3K | |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | <1% | 69 | $3K |
| 97167 | <1% | 16 | $3K | |
| 97032 | <1% | 122 | $3K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 15 | $2K |
| 11720 | <1% | 30 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 839 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 15 | $2K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 13 | $2K |
| 90677 | <1% | 53 | $2K | |
| 90716 | <1% | 81 | $2K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 12 | $2K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $2K |
| 90707 | <1% | 135 | $2K | |
| 99381 | <1% | 12 | $2K | |
| 99383 | <1% | 13 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16,592 | $2K |
| 90461 | <1% | 450 | $2K | |
| 99344 | <1% | 48 | $1K | |
| 90670 | <1% | 95 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,049 | $1K |
| 99348 | <1% | 44 | $1K | |
| 90734 | <1% | 64 | $1K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 22 | $1K |
| 87634 | <1% | 1,150 | $996.73 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 84 | $922.50 |
| G0009 | Administration of pneumococcal vaccine | <1% | 62 | $812.91 |
| 90661 | <1% | 31 | $806.18 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,441 | $761.10 |
| 93000 | <1% | 1,384 | $736.55 | |
| 97012 | <1% | 332 | $615.42 | |
| 99001 | <1% | 41 | $502.21 | |
| 90696 | <1% | 34 | $478.97 | |
| H0049 | Alcohol and/or drug screening | <1% | 12 | $474.32 |
| 81003 | <1% | 6,253 | $423.49 | |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans | <1% | 79 | $379.81 |
| 97760 | <1% | 13 | $372.59 | |
| 73630 | <1% | 1,975 | $369.06 | |
| 86580 | <1% | 79 | $343.95 | |
| 84703 | <1% | 648 | $341.01 | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 60 | $334.31 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 49 | $317.80 |
| 86480 | <1% | 26 | $297.78 | |
| 36410 | <1% | 12 | $287.35 | |
| 73610 | <1% | 1,216 | $245.84 | |
| 73130 | <1% | 1,154 | $233.71 | |
| J3490 | Unclassified drugs | <1% | 16 | $167.09 |
| 92015 | Determination of refractive state | <1% | 1,010 | $133.81 |
| 73110 | <1% | 290 | $116.18 | |
| 76377 | <1% | 30 | $100.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 335 | $72.61 |
| 73140 | <1% | 272 | $54.43 | |
| 87070 | <1% | 2,593 | $51.17 | |
| 87184 | <1% | 2,228 | $43.73 | |
| 80053 | Comprehensive metabolic panel | <1% | 52 | $41.86 |
| 87081 | <1% | 1,084 | $37.09 | |
| 76536 | <1% | 83 | $23.13 | |
| 73562 | <1% | 38 | $15.00 | |
| 69209 | <1% | 656 | $3.27 | |
| 3077F | <1% | 94 | $2.50 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 291 | $1.45 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 248 | $0.02 |
| 1159F | 0% | 2,380 | $0.00 | |
| 99080 | 0% | 325 | $0.00 | |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | 0% | 5,804 | $0.00 |
| 0521F | 0% | 190 | $0.00 | |
| 3078F | 0% | 1,839 | $0.00 | |
| G8477 | Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg | 0% | 903 | $0.00 |
| 1160F | 0% | 7,335 | $0.00 | |
| 81002 | 0% | 70 | $0.00 | |
| 1494F | 0% | 128 | $0.00 | |
| 3288F | 0% | 127 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 196 | $0.00 |
| 4040F | 0% | 25 | $0.00 | |
| 1003F | 0% | 63 | $0.00 | |
| 4013F | 0% | 226 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 27 | $0.00 |
| 0518F | 0% | 229 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 175 | $0.00 |
| 1090F | 0% | 61 | $0.00 | |
| 1158F | 0% | 133 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 198 | $0.00 |
| 3725F | 0% | 39 | $0.00 | |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | 0% | 46 | $0.00 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 0% | 32 | $0.00 |
| 73590 | 0% | 15 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 12 | $0.00 |
| 4274F | 0% | 70 | $0.00 | |
| 73030 | 0% | 13 | $0.00 | |
| 3044F | 0% | 52 | $0.00 | |
| 0001F | 0% | 1,423 | $0.00 | |
| 3080F | 0% | 29 | $0.00 | |
| 1125F | 0% | 2,834 | $0.00 | |
| 3074F | 0% | 1,727 | $0.00 | |
| 1126F | 0% | 4,054 | $0.00 | |
| 1036F | 0% | 1,895 | $0.00 | |
| 3008F | 0% | 1,586 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 922 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 71 | $0.00 |
| 3017F | 0% | 29 | $0.00 | |
| 3079F | 0% | 64 | $0.00 | |
| G8478 | Blood pressure measurement not performed or documented, reason not given | 0% | 402 | $0.00 |
| 1170F | 0% | 262 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 243 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 126 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 169 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 31 | $0.00 |
| 73090 | 0% | 126 | $0.00 | |
| 1034F | 0% | 16 | $0.00 | |
| 4008F | 0% | 84 | $0.00 | |
| 0509F | 0% | 198 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 0% | 49 | $0.00 |
| 87807 | 0% | 69 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 25 | $0.00 |
| E0776 | Iv pole | 0% | 20 | $0.00 |
| 81000 | 0% | 27 | $0.00 | |
| 3014F | 0% | 15 | $0.00 | |
| 96127 | 0% | 28 | $0.00 | |
| 3075F | 0% | 82 | $0.00 | |
| 94760 | 0% | 136 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 193 | $0.00 |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | 0% | 14 | $0.00 |
| 87077 | 0% | 14 | $0.00 | |
| 1157F | 0% | 103 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 15 | $0.00 |
| 73560 | 0% | 15 | $0.00 | |
| 85018 | 0% | 219 | $-5.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZARCHI, MENDY (OPERATIONS)